Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction

Authors:

Abstract
No abstract available
Funding Information
  • NIH (R01AR065873)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Genethon

This publication has 39 references indexed in Scilit: